Pseudomonas aeruginosa renews its virulence factors

Environmental Microbiology Reports

Volumn 8, Issue 5, 2016, Pages 564-571

  Huber, Philippe ^a,b,c,d   Basso, Pauline ^a,b,c,d   Reboud, Emeline ^a,b,c,d   Attree, Ina ^a,b,c,d  

^a UNIV GRENOBLE ALPES   (France)

^b CNRS   (France)

^c CEA GRENOBLE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992157059     PISSN: None     EISSN: 17582229     Source Type: Journal    
DOI: 10.1111/1758-2229.12443     Document Type: Review

References (48)

1. Beaufort, N., Corvazier, E., Hervieu, A., Choqueux, C., Dussiot, M., Louedec, L., et al. (2011) The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic pseudomonas aeruginosa induces anoikis of human vascular cells. Cell Microbiol 13: 1149-1167.
2. van Belkum, A., Soriaga, L.B., LaFave, M.C., Akella, S., Veyrieras, J.B., Barbu, E.M., et al. (2015) Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant pseudomonas aeruginosa. MBio 6: e01796-e01715.
3. Bleves, S., Viarre, V., Salacha, R., Michel, G.P., Filloux, A., and Voulhoux, R. (2010) Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int J Med Microbiol 300: 534-543.
4. Boukerb, A.M., Marti, R., and Cournoyer, B. (2015) Genome sequences of three strains of the Pseudomonas aeruginosa PA7 Clade. Genome Announc 3: e01366-15
5. Burrows, L.L. (2012) Pseudomonas aeruginosa twitching motility: type IV pili in action. Annu Rev Microbiol 66: 493-520.
6. Cadoret, F., Ball, G., Douzi, B., and Voulhoux, R. (2014) Txc, a new type II secretion system of pseudomonas aeruginosa strain PA7, is regulated by the TtsS/TtsR twocomponent system and directs specific secretion of the CbpE chitin-binding protein. J Bacteriol 196: 2376-2386
7. Coin, D., Louis, D., Bernillon, J., Guinand, M., and Wallach, J. (1997) LasA, alkaline protease and elastase in clinical strains of Pseudomonas aeruginosa: quantification by immunochemical methods. FEMS Immunol Med Microbiol 18: 175-184.
8. Comer, J.E., Marshall, M.A., Blanch, V.J., Deal, C.D., and Castric, P. (2002) Identification of the Pseudomonas aeruginosa 1244 pilin glycosylation site. Infect Immun 70: 2837-2845.
9. De Soyza, A., Perry, A., Hall, A.J., Sunny, S.S., Walton, K.E., Mustafa, N., et al. (2014) Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis. Eur Respir J 43: 900-903.
10. Dingemans, J., Ye, L., Hildebrand, F., Tontodonati, F., Craggs, M., Bilocq, F., et al. (2014) The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung. Pathog Dis 71: 26-38.
11. Doig, P., Todd, T., Sastry, P.A., Lee, K.K., Hodges, R.S., Paranchych, W., and Irvin, R.T. (1988) Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun 56: 1641-1646.
12. Dulon, S., Leduc, D., Cottrell, G.S., D’alayer, J., Hansen, K.K., Bunnett, N.W., et al. (2005) Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 32: 411-419.
13. Elsen, S., Huber, P., Bouillot, S., Coute, Y., Fournier, P., Dubois, Y., et al. (2014) A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia. Cell Host Microbe 15: 164-176.
14. Filloux, A. (2011) Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution, and Function. Front Microbiol 2: 155.
15. Gellatly, S.L., and Hancock, R.E. (2013) Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog Dis 67: 159-173.
16. Ghequire, M.G., and De Mot, R. (2014) Ribosomally encoded antibacterial proteins and peptides from Pseudomonas. FEMS Microbiol Rev 38: 523-568.
17. Gilchrist, F.J., Alcock, A., Belcher, J., Brady, M., Jones, A., Smith, D., et al. (2011) Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa. Eur Respir J 38: 409-414.
18. Golovkine, G., Faudry, E., Bouillot, S., Voulhoux, R., Attree, I., and Huber, P. (2014) VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells. PLoS Pathog 10: e1003939.
19. Harvey, H., Kus, J.V., Tessier, L., Kelly, J., and Burrows, L.L. (2011) Pseudomonas aeruginosa D-arabinofuranose biosynthetic pathway and its role in type IV pilus assembly. J Biol Chem 286: 28128-28137.
20. Hilker, R., Munder, A., Klockgether, J., Losada, P.M., Chouvarine, P., Cramer, N., et al. (2015) Interclonal gradient of virulence in the pseudomonas aeruginosa pangenome from disease and environment. Environ Microbiol 17: 29-46
21. Hong, Y.Q., and Ghebrehiwet, B. (1992) Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol 62: 133-138.
22. Josenhans, C., and Suerbaum, S. (2002) The role of motility as a virulence factor in bacteria. Int J Med Microbiol 291: 605-614.
23. King, J.D., Mulrooney, E.F., Vinogradov, E., Kneidinger, B., Mead, K., and Lam, J.S. (2008) lfnA from Pseudomonas aeruginosa O12 and wbuX from Escherichia coli O145 encode membrane-associated proteins and are required for expression of 2,6-dideoxy-2-acetamidino-L-galactose in lipopolysaccharide O antigen. J Bacteriol 190: 1671-1679.
24. Kos, V.N., Deraspe, M., McLaughlin, R.E., Whiteaker, J.D., Roy, P.H., Alm, R.A., et al. (2015) The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother 59: 427-436.
25. Kuang, Z., Hao, Y., Walling, B.E., Jeffries, J.L., Ohman, D.E., and Lau, G.W. (2011) Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One 6: e27091.
26. Kuo, C., Takahashi, N., Swanson, A.F., Ozeki, Y., and Hakomori, S. (1996) An N-linked high-mannose type oligosaccharide, expressed at the major outer membrane protein of Chlamydia trachomatis, mediates attachment and infectivity of the microorganism to HeLa cells. J Clin Invest 98: 2813-2818.
27. Kus, J.V., Kelly, J., Tessier, L., Harvey, H., Cvitkovitch, D.G., and Burrows, L.L. (2008) Modification of Pseudomonas aeruginosa Pa5196 type IV Pilins at multiple sites with D-Araf by a novel GT-C family Arabinosyltransferase, TfpW. J Bacteriol 190: 7464-7478.
28. Leduc, D., Beaufort, N., de Bentzmann, S., Rousselle, J.C., Namane, A., Chignard, M., and Pidard, D. (2007) The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis. Infect Immun 75: 3848-3858.
29. Maatallah, M., Cheriaa, J., Backhrouf, A., Iversen, A., Grundmann, H., Do, T., et al. (2011) Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6: e25617.
30. Mai-Prochnow, A., Bradbury, M., and Murphy, A.B. (2015) Draft genome sequence of Pseudomonas aeruginosa ATCC 9027 (DSM 1128), an important rhamnolipid surfactant producer and sterility testing strain. Genome Announc 3: e01259-15.
31. Marceau, M., and Nassif, X. (1999) Role of glycosylation at Ser63 in production of soluble pilin in pathogenic Neisseria. J Bacteriol 181: 656-661.
32. Mariencheck, W.I., Alcorn, J.F., Palmer, S.M., and Wright, J.R. (2003) Pseudomonas aeruginosa elastase degrades surfactant proteins a and D. Am J Respir Cell Mol Biol 28: 528-537.
33. Michel-Briand, Y., and Baysse, C. (2002) The pyocins of Pseudomonas aeruginosa. Biochimie 84: 499-510.
34. Morita, Y., Tomida, J., and Kawamura, Y. (2012) Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant pseudomonas aeruginosa clinical isolate PA7. Microbiology 158: 1071-1083.
35. Morita, Y., Tomida, J., and Kawamura, Y. (2015) Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon. Front Microbiol 6: 8.
36. Murray, T.S., Ledizet, M., and Kazmierczak, B.I. (2010) Swarming motility, secretion of type 3 effectors and bio-film formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates. J Med Microbiol 59: 511-520.
37. Pirnay, J.P., Bilocq, F., Pot, B., Cornelis, P., Zizi, M., Van Eldere, J., et al. (2009) Pseudomonas aeruginosa population structure revisited. PLoS One 4: e7740
38. Reboud, E., Elsen, S., Bouillot, S., Golovkine, G., Basso, P., Jeannot, K., et al. (2016) Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide. Environ Microbiol doi: 10.1111/1462-2920.13262.
39. Roy, P.H., Tetu, S.G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., et al. (2010) Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS One 5: e8842.
40. Schaber, J.A., Carty, N.L., McDonald, N.A., Graham, E.D., Cheluvappa, R., Griswold, J.A., and Hamood, A.N. (2004) Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa. J Med Microbiol 53: 841-853.
41. Schmidtchen, A., Holst, E., Tapper, H., and Bjorck, L. (2003) Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb Pathog 34: 47-55.
42. Smith, D., Spanel, P., Gilchrist, F.J., and Lenney, W. (2013) Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res 7: 044001.
43. Szymanski, C.M., Burr, D.H., and Guerry, P. (2002) Campylobacter protein glycosylation affects host cell interactions. Infect Immun 70: 2242-2244.
44. Thrane, S.W., Taylor, V.L., Freschi, L., Kukavica-Ibrulj, I., Boyle, B., Laroche, J., et al. (2015) The widespread multidrug-resistant serotype O12 Pseudomonas aeruginosa clone emerged through concomitant horizontal transfer of serotype antigen and antibiotic resistance gene clusters. MBio 6: e01396-e01315.
45. Toska, J., Sun, Y., Carbonell, D.A., Foster, A.N., Jacobs, M.R., Pearlman, E., and Rietsch, A. (2014) Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates. PLoS One 9: e86829.
46. Voisin, S., Kus, J.V., Houliston, S., St-Michael, F., Watson, D., Cvitkovitch, D.G., et al. (2007) Glycosylation of Pseudomonas aeruginosa strain Pa5196 type IV pilins with mycobacterium-like alpha-1,5-linked d-Araf oligosaccharides. J Bacteriol 189: 151-159.
47. Williams, B.J., Dehnbostel, J., and Blackwell, T.S. (2010) Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15: 1037-1056.
48. Witney, A.A., Gould, K.A., Pope, C.F., Bolt, F., Stoker, N.G., Cubbon, M.D., et al. (2014) Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa. Clin Microbiol Infect 20: O609-O618.